Prevalence of hepatitis C serum antibody in autoimmune diseases
Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2009
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22250
- Acceso en línea:
- https://doi.org/10.1016/j.jaut.2009.02.017
https://repository.urosario.edu.co/handle/10336/22250
- Palabra clave:
- Autoantibody
Cytomegalovirus antibody
Hepatitis b antibody
Hepatitis c antibody
Protozoon antibody
Antibody detection
Antiphospholipid syndrome
Article
Autoimmune disease
Churg strauss syndrome
Controlled study
Cryoglobulinemia
Diabetes mellitus
Enteritis
Giant cell arteritis
Hashimoto disease
Hepatitis c
Hepatitis c virus
Human
Major clinical study
Microscopic polyangiitis
Multiple sclerosis
Myositis
Pemphigus vulgaris
Prevalence
Primary biliary cirrhosis
Priority journal
Rheumatoid arthritis
Sjoegren syndrome
Systemic lupus erythematosus
Toxoplasma gondii
Wegener granulomatosis
Aged
Autoantibodies
Autoimmune diseases
Female
Hepatitis c
Hepatitis c antibodies
Humans
Male
Middle aged
Prevalence
Antiphospholipids syndrome
Autoantibodies
Autoimmune diseases
Cryoglobulinemia
Hepatitis-c
Inflammatory bowel diseases
Pemphigus vulgaris
Thyroid autoimmune diseases
- Rights
- License
- Abierto (Texto Completo)
Summary: | Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from the same countries and with similar age and sex distribution. All sera were tested for the presence of serum anti-hepatitis C virus (HCV) antibodies as well as antibodies directed at other infectious agents and autoantibodies. Results: Anti-HCV antibody was detected in 115/1322 (8.7%) of patients with AID and 0.4% of matched healthy controls (P less than 0.0001). The prevalence of anti-HCV antibody was significantly higher in 7/18 different AID (i.e. cryoglobulinemia, mixed cryoglobulinemia pemphigus vulgaris, vasculitis, secondary anti-phospholipid syndrome, Hashimoto's thyroiditis, and inflammatory bowel disease) compared to controls. Patients with AID and serum anti-HCV positivity had an increased prevalence of antibodies against hepatitis B virus, Toxoplasma gondii and Cytomegalovirus as opposed to a lower frequency of serum autoantibodies. Conclusions: The enhanced prevalence of anti-HCV serum antibodies in AID may suggest a role for HCV in tolerance to breakdown, similarly to its established role in mixed cryoglobulinemia. This immune mediated effect does not rule out the role of other infectious agents. © 2009. |
---|